Automate Your Wheel Strategy on AGL
With Tiblio's Option Bot, you can configure your own wheel strategy including AGL - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol AGL
- Rev/Share 14.2597
- Book/Share 0.9881
- PB 0.874
- Debt/Equity 0.1012
- CurrentRatio 1.163
- ROIC -0.7647
- MktCap 357895831.0
- FreeCF/Share -0.1705
- PFCF -5.0727
- PE -1.1322
- Debt/Assets 0.0242
- DivYield 0
- ROE -0.6459
- Rating C-
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 3
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | AGL | Bernstein | Outperform | Market Perform | -- | $1.4 | Aug. 20, 2025 |
| Downgrade | AGL | Citigroup | Buy | Neutral | -- | $1 | Aug. 6, 2025 |
| Upgrade | AGL | Citigroup | Neutral | Buy | -- | $5 | April 25, 2025 |
| Upgrade | AGL | Bernstein | Market Perform | Outperform | -- | $8.5 | April 8, 2025 |
| Initiation | AGL | Needham | -- | Hold | -- | -- | Jan. 10, 2025 |
| Upgrade | AGL | Citigroup | Sell | Neutral | $1.75 | $2.25 | Jan. 10, 2025 |
| Initiation | AGL | Macquarie | -- | Neutral | -- | -- | Dec. 16, 2024 |
| Initiation | AGL | Bernstein | -- | Market Perform | -- | $2.5 | Dec. 11, 2024 |
| Downgrade | AGL | BofA Securities | Buy | Underperform | -- | $3 | Oct. 2, 2024 |
News
AGL Investor News: If You Have Suffered Losses in agilon health, inc. (NYSE: AGL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Published: October 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of agilon health, inc. (NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the investing public.
Read More
AGL Investor News: If You Have Suffered Losses in agilon health, inc. (NYSE: AGL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Published: October 17, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of agilon health, inc. (NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the investing public.
Read More
AGL Investor News: Rosen Law Firm Encourages agilon health, inc. Investors to Inquire About Securities Class Action Investigation - AGL
Published: October 10, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Oct. 10, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of agilon health, inc. (NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the investing public.
Read More
Rosen Law Firm Encourages agilon health, inc. Investors to Inquire About Securities Class Action Investigation – AGL
Published: October 09, 2025 by: Business Wire
Sentiment: Neutral
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of agilon health, inc. (NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the investing public. So What: If you purchased agilon health securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arr.
Read More
New Strong Sell Stocks for October 1st
Published: October 01, 2025 by: Zacks Investment Research
Sentiment: Negative
AGL, PLAY and CCRN have been added to the Zacks Rank #5 (Strong Sell) List on October 1, 2025.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
Published: September 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. (“agilon” or the “Company”) (NYSE: AGL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
Published: September 08, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Sept. 8, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. ("agilon" or the "Company") (NYSE: AGL).
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
Published: September 02, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. (“agilon” or the “Company”) (NYSE: AGL).
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
Published: August 27, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Aug. 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. ("agilon" or the "Company") (NYSE: AGL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
Published: August 25, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. (“agilon” or the “Company”) (NYSE: AGL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL
Published: August 21, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. (“agilon” or the “Company”) (NYSE: AGL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read More
Johnson Fistel Commences Investigation of Agilon Health, Inc.
Published: August 05, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a shareholder rights law firm, announces that it is investigating potential claims on behalf of investors of Agilon Health, Inc. (NYSE: AGL) regarding possible violations of federal securities laws.
Read More
INVESTOR ALERT: Investigation of agilon health, inc. (AGL) Announced by Holzer & Holzer, LLC
Published: August 05, 2025 by: GlobeNewsWire
Sentiment: Neutral
ATLANTA, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether agilon health, inc. (“agilon health” or the “Company”) (NYSE: AGL) complied with federal securities laws. On August 4, 2025, agilon health announced that its CEO and President had resigned and that it was “suspending its previously issued full-year 2025 financial guidance and related assumptions.” Following this news, the price of the Company's stock dropped.
Read More
New Research Underscores the Important Role of Value-Based Care (VBC) in Improving Primary Care Access for Traditional Medicare Patients
Published: June 09, 2025 by: Business Wire
Sentiment: Neutral
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced new research demonstrating the promising role of value-based care (VBC) in maintaining primary care for senior patients when supported by agilon health, a VBC-enablement company. The study was published in the May 2025 issue of Health Affairs Scholar. “Primary care is foundational for Medicare beneficiaries, especially those with c.
Read More
agilon health, inc. (AGL) Q1 2025 Earnings Call Transcript
Published: May 06, 2025 by: Seeking Alpha
Sentiment: Neutral
agilon health, inc. (NYSE:AGL ) Q1 2025 Results Conference Call May 6, 2025 4:30 PM ET Company Participants Evan Smith - Senior Vice President of Investor Relations Steve Sell - Chief Executive Officer Jeff Schwaneke - Chief Financial Officer Conference Call Participants Stephen Baxter - Wells Fargo Elizabeth Anderson - Evercore ISI Jailendra Singh - Truist Securities Justin Lake - Wolfe Research Amir Farahani - Bernstein Lisa Gill - JPMorgan Ryan Langston - TD Cowen Joanna Gajuk - Bank of America Ryan Daniels - William Blair Michael Ha - Baird Matthew Shea - Needham Daniel Grosslight - Citi Jenny Shen …
Read More
Agilon Health (AGL) Reports Break-Even Earnings for Q1
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Neutral
Agilon Health (AGL) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.01 per share a year ago.
Read More
Bloodied But Unbowed, Agilon Health Can Profit From Improving Market Dynamics
Published: April 10, 2025 by: Seeking Alpha
Sentiment: Neutral
agilon health's stock has surged over 165% YTD in 2025 despite a 77% decline since its 2021 IPO, driven by CMS rate hikes for 2026. The company faces challenges with significant operating losses and industry headwinds, but remains committed to value-based care over fee-for-service models. agilon's business model involves global capitation fees from health plan payors, focusing on Medicare Advantage through a network of physician partners.
Read More
Agilon (AGL) Moves 26.1% Higher: Will This Strength Last?
Published: April 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Agilon (AGL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Read More
Is Agilon Health (AGL) Stock Outpacing Its Medical Peers This Year?
Published: March 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Here is how Agilon Health (AGL) and Paragon 28, Inc. (FNA) have performed compared to their sector so far this year.
Read More
Agilon Health Adjusts To Recovery Phase, Analyst Is Cautious On Near-Term Fundamentals
Published: March 18, 2025 by: Benzinga
Sentiment: Neutral
J.P. Morgan analyst Lisa C. Gill, with a Neutral rating, updated estimates for Agilon Health, Inc. AGL following fourth-quarter results posted last month.
Read More
Is Agilon Health (AGL) Outperforming Other Medical Stocks This Year?
Published: March 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Here is how Agilon Health (AGL) and Akero Therapeutics, Inc. (AKRO) have performed compared to their sector so far this year.
Read More
agilon health, inc. (AGL) Q4 2024 Earnings Call Transcript
Published: February 26, 2025 by: Seeking Alpha
Sentiment: Neutral
agilon health, inc. (NYSE:AGL ) Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ET Company Participants Evan Smith - Senior Vice President of Investor Relations Steven Sell - Chief Executive Officer Jeffrey Schwaneke - Chief Financial Officer Conference Call Participants Stephen Baxter - Wells Fargo Justin Lake - Wolfe Research Jack Slevin - Jefferies Ryan Langston - TD Cowen Amir Farahani - Bernstein Jailendra Singh - Truist Securities Michael Ha - Baird Elizabeth Anderson - Evercore Adam Ron - Bank of America Ryan Daniels - William Blair Whit Mayo - Leerink Partners Daniel Grosslight - Citi David Larsen …
Read More
Agilon (AGL) Reports Q4 Earnings: What Key Metrics Have to Say
Published: February 25, 2025 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for Agilon (AGL) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
agilon health to Participate in TD Cowen's 45th Annual Health Care Conference
Published: February 21, 2025 by: Business Wire
Sentiment: Neutral
WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health in our communities, announced that it will participate in the 45th Annual TD Cowen Healthcare Conference including a fireside chat presentation on Wednesday, March 5 at 9:50 AM Eastern Time. Interested investors and other parties may listen to a simultaneous webcast of the presentation by visiting the “Events & Presentations” section of agilon health's investor.
Read More
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of agilon health, inc. (NYSE: AGL) and Encourages Long-Term Investors to Contact the Firm
Published: February 17, 2025 by: GlobeNewsWire
Sentiment: Neutral
PHILADELPHIA, Feb. 17, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating agilon health, inc. (NYSE: AGL) on behalf of the company's long-term shareholders.
Read More
About Agilon Health, Inc. (AGL)
- IPO Date 2021-04-15
- Website https://agilonhealth.com
- Industry Medical - Care Facilities
- CEO Steven Jackson Sell
- Employees 1076